- Home
- TMCI vs BGY Comparison
TMCI vs BGY Comparison
Compare TMCI & BGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMCI
- BGY
- Stock Information
- Founded
- TMCI 2014
- BGY 2007
- Country
- TMCI United States
- BGY United States
- Employees
- TMCI N/A
- BGY N/A
- Industry
- TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- BGY Trusts Except Educational Religious and Charitable
- Sector
- TMCI Health Care
- BGY Finance
- Exchange
- TMCI Nasdaq
- BGY Nasdaq
- Market Cap
- TMCI 516.6M
- BGY 487.0M
- IPO Year
- TMCI 2021
- BGY N/A
- Fundamental
- Price
- TMCI $6.82
- BGY $5.65
- Analyst Decision
- TMCI Hold
- BGY
- Analyst Count
- TMCI 6
- BGY 0
- Target Price
- TMCI $8.92
- BGY N/A
- AVG Volume (30 Days)
- TMCI 404.0K
- BGY 208.4K
- Earning Date
- TMCI 05-08-2025
- BGY 01-01-0001
- Dividend Yield
- TMCI N/A
- BGY 7.41%
- EPS Growth
- TMCI N/A
- BGY N/A
- EPS
- TMCI N/A
- BGY N/A
- Revenue
- TMCI $210,819,000.00
- BGY N/A
- Revenue This Year
- TMCI $10.85
- BGY N/A
- Revenue Next Year
- TMCI $10.07
- BGY N/A
- P/E Ratio
- TMCI N/A
- BGY N/A
- Revenue Growth
- TMCI 7.54
- BGY N/A
- 52 Week Low
- TMCI $3.92
- BGY $4.68
- 52 Week High
- TMCI $11.33
- BGY $5.66
- Technical
- Relative Strength Index (RSI)
- TMCI 41.89
- BGY 56.71
- Support Level
- TMCI $6.94
- BGY $5.22
- Resistance Level
- TMCI $7.73
- BGY $5.73
- Average True Range (ATR)
- TMCI 0.52
- BGY 0.09
- MACD
- TMCI 0.10
- BGY 0.03
- Stochastic Oscillator
- TMCI 50.27
- BGY 79.22
About TMCI Treace Medical Concepts Inc.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.
About BGY Blackrock Enhanced International Dividend Trust
Blackrock Enhanced International Dividend Trust has an investment objective to provide current income and current gains, with a secondary objective of long-term capital appreciation. The Trust seeks to achieve its objectives by investing in equity securities of companies engaged in the energy and natural resources business and equity derivatives with exposure to the energy and natural resources industry.